$22.32 -0.96 (%) Medicines Co - NASDAQ

Sep. 30, 2014 | 04:00 PM

Partner Headlines

  1. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 11:04AM EST
  2. Benzinga's Top Downgrades

    Benzinga | Apr. 17, 2014 | 08:02AM EST
  3. Benzinga's Top Downgrades

    Benzinga | Apr. 2, 2014 | 08:03AM EST
  4. Medicines Co.

    IBD | Apr. 1, 2014 | 18:53PM EST
  5. Mid-Afternoon Market Update: Compuware Holds Onto Gains, Clearwire Remains Down

    Benzinga | Apr. 1, 2014 | 16:00PM EST
  6. Stocks Higher In Afternoon; Thor Industires Jumps

    IBD | Apr. 1, 2014 | 13:40PM EST
  7. Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines Co. Falls

    Benzinga | Apr. 1, 2014 | 12:39PM EST
  8. Medicines Co. Down On Setback In Hospira Patent Case

    IBD | Apr. 1, 2014 | 12:12PM EST
  9. Stocks Hitting 52-Week Lows

    Benzinga | Apr. 1, 2014 | 10:30AM EST
  10. Mid-Morning Market Update: Markets Gain; Ford March Sales Rise 3%

    Benzinga | Apr. 1, 2014 | 10:28AM EST
  11. Morning Market Losers

    Benzinga | Apr. 1, 2014 | 09:53AM EST
  12. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 1, 2014 | 08:21AM EST
  13. Medicines Co. earnings miss

    IBD | Feb. 19, 2014 | 18:54PM EST
  14. Earnings Scheduled For February 19, 2014

    Benzinga | Feb. 19, 2014 | 04:30AM EST
  15. FDA nixes Medicines' drug

    IBD | Feb. 13, 2014 | 18:33PM EST
  16. Mid-Afternoon Market Update: Market Rally Levels Out As Time Warner/Comcast Deal Holds The Spotlight

    Benzinga | Feb. 13, 2014 | 15:48PM EST
  17. Mid-Day Market Update: U.S. Stocks Rise; Orbitz Shares Surge On Upbeat Results

    Benzinga | Feb. 13, 2014 | 12:44PM EST
  18. Medicines Co. Downgraded After FDA Panel Rejects Drug

    IBD | Feb. 13, 2014 | 12:38PM EST
  19. Mid-Morning Market Update: Markets Drop; Comcast To Acquire Time Warner Cable For $45.2B

    Benzinga | Feb. 13, 2014 | 10:25AM EST
  20. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 13, 2014 | 10:14AM EST
  21. UPDATE: Credit Suisse Downgrades The Medicines Company Following Negative Cangrelor Panel

    Benzinga | Feb. 13, 2014 | 08:38AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 13, 2014 | 08:18AM EST
  23. UPDATE: The Medicines Co. Reminds Investors of FDA CRDAC Meeting Today, Says Proposing Cangrelor Be Indicated to Maintain P2Y12 Inhibition

    Benzinga | Feb. 12, 2014 | 07:07AM EST
  24. Mid-Afternoon Market Update: Red Robin Continues to Rally as The Medicines Company Drops

    Benzinga | Feb. 10, 2014 | 16:16PM EST
  25. Leaders Hold Near Buy Points Despite Monday Sell-Off

    IBD | Jan. 14, 2014 | 16:31PM EST
  26. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD | Jan. 13, 2014 | 18:07PM EST
  27. Scanning Leading Stocks For Earnings Growth In 2014

    IBD | Dec. 18, 2013 | 18:00PM EST
  28. Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Dec. 10, 2013 | 04:08AM EST
  29. Medicines acquires Rempex

    IBD | Dec. 4, 2013 | 18:36PM EST
  30. Benzinga's M&A Chatter for Wednesday December 4, 2013

    Benzinga | Dec. 4, 2013 | 17:21PM EST
  31. Medicines Co. Acquires Rempex Pharma; Street Applauds

    IBD | Dec. 4, 2013 | 11:21AM EST
  32. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Dec. 4, 2013 | 07:12AM EST
  33. Five Medical Stocks Leaders Trade Near New Highs

    IBD | Nov. 22, 2013 | 18:49PM EST
  34. A Few Stocks Form Bases, But Have Flaws

    IBD | Nov. 20, 2013 | 18:30PM EST
  35. Strong Pipeline Expected To Drive Growth At Medicines Co.

    IBD | Nov. 15, 2013 | 18:30PM EST
  36. Medicines Co. Mostly Steady After Low-Volume Breakout

    IBD | Nov. 12, 2013 | 17:37PM EST
  37. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD | Nov. 11, 2013 | 17:13PM EST
  38. Santarus Earnings Should Top 4 Hot Small-Cap Medicals

    IBD | Nov. 7, 2013 | 08:02AM EST
  39. Top 4 NASDAQ Stocks In The Drug Manufacturers-Other Industry With The Highest EPS Estimates

    Benzinga | Nov. 7, 2013 | 04:19AM EST
  40. LinkedIn, Alliance Fiber Lead Q3 Young Gun Earnings

    IBD | Oct. 30, 2013 | 08:02AM EST
  41. Medicines Co. In Late Stages Of Base Formation

    IBD | Oct. 25, 2013 | 16:38PM EST
  42. Medicines Co. sales topped

    IBD | Oct. 23, 2013 | 18:47PM EST
  43. Medicines Co. Reports Mixed Q3 As New Products Await

    IBD | Oct. 23, 2013 | 16:14PM EST
  44. Medicines Co. Sales Beat Estimates As Angiomax Grows

    IBD | Oct. 23, 2013 | 12:15PM EST
  45. UPDATE: Leerink Swann Raises PT on The Medicines Company Following Analyst Meeting

    Benzinga | Oct. 10, 2013 | 10:56AM EST
  46. The Medicines Company, Alnylam Announce Advance Development Candidate for Treatment of Hypercholesterolemia

    Benzinga | Oct. 9, 2013 | 06:10AM EST
  47. The Medicines Company's Publishes Phase III Data from Trials of IV Cangrelor

    Benzinga | Sep. 3, 2013 | 07:10AM EST
  48. UPDATE: Bank of America Upgrades Medicines Company on Leverage

    Benzinga | Aug. 15, 2013 | 09:21AM EST
  49. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

    Benzinga | Aug. 13, 2013 | 05:55AM EST
  50. The Medicines Company Announces Proposed Public Offering of 5.5 Million Shares of Common Stock

    Benzinga | Aug. 12, 2013 | 16:20PM EST
Trading Center